Home / Cancer and immune system / Capecitabine
ATC L01BC06 · Antineoplastic Agents
Capecitabine shortage
As of 31 Oct 2026, Capecitabine has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 7 products.
Countries4/5
Products7packs or presentations
Short since26 May 20233.4 years ago
Earliest return29 Nov 2026company estimate
No return date3products
Main reasonManufacturing problem
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | CAPECITABINA ZENTIVA | ZENTIVA ITALIA S.R.L. | 26 May 2023 | not given | Increased demand Elevata richiesta |
| IT | CAPECITABINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 11 Feb 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| ES | CAPECITABINA KERN PHARMA 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos (Blister PVC/PVDC-ALUMINIO) | Kern Pharma S.L. | 30 Sep 2026 | 28 Jan 2027 | Not stated |
| ES | CAPECITABINA ACCORD 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG 120 comprimidos | Accord Healthcare S.L.U. | 29 Oct 2026 | 29 Nov 2026 | Not stated |
| AT | Capecitabin Sandoz 150 mg - Filmtabletten, 60 Stück | Sandoz GmbH | 15 Feb 2025 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| BE | Capecitabine Accord 500 mg film-coat. tabl. 120 (120 x 1) UD | Accord Healthcare | 30 Jul 2026 | 30 Nov 2026 | Manufacturing problem Delay in production |
| BE | Xeloda 500 mg tabl. 120 | Cheplapharm Arzneimittel | 15 Oct 2026 | 30 Nov 2026 | Increased demand |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.